Table 2 Impact score factors
Overall | T-status | HU/U status | p Valuea | |
|---|---|---|---|---|
Variables | ||||
Age, years | 0.237 | |||
> 60 | 27 | 14 (35.9%) | 13 (24.5%) | |
≤ 60 | 65 | 25 (64.1%) | 40 (75.5%) | |
Bilirubin, mg/dl | 0.050 | |||
0-0.99 | 53 | 28 (77.8%) | 25 (49.0%) | |
1-1.99 | 27 | 6 (16.7%) | 21 (41.2%) | |
2-3.99 | 6 | 2 (5.6%) | 4 (7.8%) | |
≥ 4 | 1 | 0 | 1 (2.0%) | |
Creatinine Clearance, ml/min | 0.752 | |||
≥ 50 | 75 | 30 (85.7%) | 45 (88.2%) | |
30-49 | 11 | 5 (14.3%) | 6 (11.8%) | |
< 30 | 0 | 0 | 0 | |
Dialysis between listing and transplant | 5 | 1 (2.7%) | 4 (7.5%) | 0.645 |
Female sex | 19 | 12 (30.8%) | 7 (13.2%) | 0.040 |
Diagnosis | 0.036 | |||
Ischemic | 46 | 16 (41.0%) | 30 (56.6%) | |
Idiopathic | 34 | 20 (51.3%) | 14 (26.4%) | |
Congenital | 5 | 0 | 5 (9.4%) | |
Other | 7 | 3 (7.7%) | 4 (7.5%) | |
Infection | 13 | 1 (2.7%) | 12 (22.6%) | 0.026 |
IABP | 11 | 1 (2.7%) | 10 (18.9%) | 0.024 |
Mechanical ventilation prior to Tx | 2 | 0 | 2 (3.8%) | 0.510 |
Circulatory support | 8 | 0 | 8 (15.1%) | 0.019 |
Ventricular assist deviced | <0.001 | |||
No VAD | 50 | 34 (87.2%) | 16 (32.7%) | |
Early Generation PFb | 23 | 3 (7.7%) | 20 (40.8%) | |
New Generation CFc | 3 | 0 | 3 (6.1%) | |
Heartmate II | 12 | 2 (5.1%) | 10 (20.4%) |